发明名称 |
Treatment of subnormal bone mineral density. |
摘要 |
A method of treating an individual to increase the individual's bone mineral density (BMD) is disclosed. The method includes co-administering a calcitonin-like agent and a DHEA-like agent. Also disclosed are methods for potentiating the effect of treatment with a calcitonin-like agent on BMD and for increasing BMD in an individual being treated with DHEA, e.g., for treatment of systemic lupus erythematosus (SLE). |
申请公布号 |
ZA200203527(B) |
申请公布日期 |
2003.08.04 |
申请号 |
ZA20020003527 |
申请日期 |
2002.05.03 |
申请人 |
GENELABS TECHNOLOGIES, INC. |
发明人 |
KENNETH E. SCHWARTZ |
分类号 |
A61K;A61K31/565;A61K31/66;A61K38/23;A61P;A61P19/10 |
主分类号 |
A61K |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|